Review Articles

  1. “Theranostics with Photodynamic Therapy for Personalized Medicine: To See and to Treat” Y. Wang, J. N. Staudinger, T. L. Mindt, G. Gasser Theranostics 2023, 13, 5501-5504. DOI:
  2. “The Race for Hydroxamate-Based Zirconium-89 Chelators” I. V. J. Feiner, M. Brandt, J. Cowell, T. Demuth, D. Vugts, G. Gasser and T. L. Mindt Cancers 2021, 13, 4466 (invited review). DOI:
  3. “1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogate for the Stabilisation of Linear Peptides with Biological Activity” L. M. Recnik, W. Kandioller, T. L. Mindt Molecules 2020, 25, 3576-3602. DOI: 10.3390/molecules25163576
  4. “Manganese in Medical Imaging – Opportunities and Challenges“ M. Brandt, J. Cardinale, I. Rausch, T. L. Mindt Journal of Labelled Compounds and Radiopharmaceuticals 2019, 62, 541-551 (invited review; among the top 10% of most downloaded papers published between January 2018 and December 2019). DOI: 10.1002/jlcr.3754
  5. “Mini Review: Targeted Radiopharmaceuticals Incorporating Reversible, Low Molecular Weight Albumin Binders”  M. Brandt, J. Cardinale, C. Giammei,  X. Guarrotxena, B. Happl,  N. Jouini, T. L. Mindt Nuclear Medicine and Biology 2019, 70, 46-52 (invited review). DOI: 10.1016/j.nucmedbio.2019.01.006
  6. “An Overview on PET-Radiochemistry: Part 2 – Radiometals” M. Brandt, J. Cardinale, M. Aulsebrook, G. Gasser, T. L. Mindt Journal of Nuclear Medicine 2018, 59, 1500-1506 (invited review). DOI: 10.2967/jnumed.117.190801
  7. “1,2,3-Triazoles as Amide Bond Surrogates in Peptidomimetics” I. E. Valverde, T. L. Mindt Chimia 2013, 4, 262-266. DOI: 10.2533/chimia.2013.262
  8. “Click-to-Chelate: Development of Technetium- and Rhenium-Tricarbonyl Labeled Radiopharmaceuticals” C. A. Kluba, T. L. Mindt Molecules 2013, 18, 3206-3226. DOI: 10.3390/molecules18033206
  9. ”Concepts for the design of metal chelating systems using the copper catalyzed azide-alkyne cycloaddition” H. Struthers, T. L. Mindt, R. Schibli Dalton Transactions 2010, 39, 675. (highlighted as cover page illustration). DOI: 10.1039/b912608b
  10. “Strategies for the Development of Novel Tumor Targeting Technetium and Rhenium Radiopharmaceuticals” T. L. Mindt, H. Struthers, E. Garcia-Garayoa, D. Desbouis, R. Schibli Chimia2007, 61, 725. DOI: 10.2533/chimia.2007.725